• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Telomerase activity and p53-induced apoptosis

Research Project

Project/Area Number 09671682
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Obstetrics and gynecology
Research InstitutionTottori University

Principal Investigator

KIGAWA Junzo  Tottori Univ. Sch. of Med., Obstetrics and Gynecology, Associated Professor, 医学部, 助教授 (00177784)

Co-Investigator(Kenkyū-buntansha) TERAKAWA Naoki  Tottori Univ. Sch. of Med., Obstetrics and Gynecology, Professor, 医学部, 教授 (90163906)
KANAMORI Yasunobu  Tottori Univ. Sch. of Med., Obstetrics and Gynecology, Assistant, 医学部, 助手 (70283984)
Project Period (FY) 1997 – 1999
Keywordstelomerae / ovarian cancer apoptosis / p53 / gene-therapy / telomere
Research Abstract

Although p53 gene mutation is frequently seen in ovarian cancer, the function of p53 gene in chemosensitivity is not conclusively defined. First, we examined the relationship between chemotherapy-induced apoptosis through p53 pathway and chemosensitivity in ovarian cancer. The study suggests that p53-dependent apoptosis in tumors is strongly related to the sensitivity to chemotherapy in epithelial ovarian cancer. Next, we developed a new recombinant adenovirus carrying a wild-type p53 gene (AxCAp53) and examined the combination effect of p53 gene transfer and cis-diamminedichloroplatinum (II)(CDDP) in an ovarian cancer cell line, SK-OV-3, with deletion of the p53 gene. AxCAp53 showed a relatively high efficiency of gene transduction, and increased sensitivity to CDDP in the SK-OV-3 cells. It was found that the sensitivity of the cells to CDDP correlated to the infectious units of virus per cell of AxCAp53 in which p53 may be a potential strategy for the therapy of CDDP resistant ovarian cancer.
To elucidate the relationship between telomerase activity and chemosensitivity in epithelial ovarian cancer, telomerase activity and telomere length were investigated before and after chemotherapy. And then we found that telomerase activity may relate to chemosensitivity in epithelial ovarian cancer. While, telomerase activity may be associated with development and extension of epithelial ovarian cancer, but there is not relationship between p53 gene status and telomerase activity. Furthermore, we examined whether and how the activity of telomerase contributes p53-induced apoptosis in ovarian cancer cells. It is concluded that telomerase does not contribute p53- induced apoptosis. Therefore telomerase may be a new target for gene-therapy.

  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Minagawa, Y.: "The outcome of radiation therapy in elderly patients with advanced cervical cancer"Int. J. Gynecol. Obstet.. 58. 305-309 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kigawa, J.: "Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer"Cancer. 82. 697-702 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oishi, T.: "Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer"Obstet Gynecol.. 91. 568-571 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kigawa, J.: "Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer"Clin. Cancer Res.. 4. 1737-1741 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kanamori, Y.: "A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells"Eur. J. Cancer. 34. 1802-1806 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sato, S.: "Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma"Cancer. 86. 1307-1313 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N: "Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer"Cancer. 82. 697-702 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oishi t, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N: "Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer"Obstet Gynecol. 91. 568-571 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kigawa J, Minagawa Y, Cheng X, Terakawa N: "Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer"Clin Cancer Res. 4. 1737-1741 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimomura T, Fujiwara H, Ikawa S, Kigawa J, Terakawa N: "Effect of taxol on blood cells"Lancet. 352. 541-542 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okada M, Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Oishi T, Terakawa N: "Alterations of the p53 gene and p53 protein expression in epithelial ovarian cancer before and after chemotherapy"Int J Clin Oncol. 3. 191-203 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kanamori Y, Kigawa J, Minagawa Y, Irie T, Oishi T, Shimada M, Takahashi M, Nakamura T, Sato K, Terakawa N: "A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-detected ovarian cancer cells"Eur J Cancer. 34. 1802-1806 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sato S, Kigawa J, Minagawa Y, Okada M, Shimada M, Takahashi M, Kamazawa S, Terakawa N: "Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma"Cancer. 86. 1307-1313 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kigawa J, Takahashi M, Minagawa Y, Oishi T, Sugiyama T, Yakuhiji M, Terakawa N: "Topoisomerase I activity and response to second-line chemotherapy consisting of camptothecin-I andcisplatin in patients with ovarian cancer"Int J Cancer. 84. 521-524 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Minagawa Y, Kigawa J, Itamochi H, Kanamori Y, Shimada M, Takahashi M, Terakawa N: "Cisplatin-Resistant HeLa Cells are Resistant to Apoptosis via p53-dependent et -independent pathway"Jpn J Cancer Res. 90. 1373-1379 (1999)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi